What Fluoroquinolones Have the Highest Risk of Aortic Aneurysm? A Case/Non-case Study in VigiBase®

J Gen Intern Med. 2019 Apr;34(4):502-503. doi: 10.1007/s11606-018-4774-2.

Agnès Sommet¹, Justine Bénévent¹, Vanessa Rousseau¹, Leila Chebane¹, Antonios Douros^{2

3

4}, Jean-Louis Montastruc¹, François Montastruc^{5

6}

¹ Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, INSERM UMR 1027, CIC 1426, Toulouse University Hospital, Faculty of Medicine, University of Toulouse, Toulouse, France.
² Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada.
³ Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montréal, Québec, Canada.
⁴ Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Clinical Pharmacology and Toxicology, Berlin, Germany.
⁵ Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, INSERM UMR 1027, CIC 1426, Toulouse University Hospital, Faculty of Medicine, University of Toulouse, Toulouse, France. [email protected].
⁶ Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montréal, Québec, Canada. [email protected].

No abstract available

Keywords: aortic aneurysms; aortic dissection; fluoroquinolones; levofloxacin.

MeSH terms